Mani Foroohar
Stock Analyst at Leerink Partners
(0.51)
# 4,006
Out of 4,411 analysts
944
Total ratings
43.2%
Success rate
-2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mani Foroohar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Initiated Coverage: Buy | $12 | $7.00 | +71.43% | 1 | Jun 4, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $17 | $6.93 | +145.31% | 64 | May 15, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $100 → $154 | $101.55 | +51.65% | 54 | May 15, 2026 | |
| ENGN enGene Therapeutics | Downgraded: Hold | $14 → $2 | $1.75 | +14.29% | 13 | May 8, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | $27 → $35 | $14.55 | +140.55% | 52 | Apr 27, 2026 | |
| CAMP Camp4 Therapeutics | Maintained: Buy | $8 → $9 | $4.13 | +117.92% | 7 | Apr 2, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | $7 → $11 | $2.80 | +292.86% | 55 | Mar 27, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Hold | n/a | $76.55 | - | 56 | Mar 26, 2026 | |
| MRNA Moderna | Maintained: Sell | $12 | $55.40 | -78.34% | 89 | Feb 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $370 → $351 | $281.90 | +24.51% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $100 | $73.09 | +36.82% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $86 | $66.64 | +29.05% | 76 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $2 | $0.68 | +194.12% | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $4.75 | +278.95% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $74 | $52.02 | +42.25% | 27 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.67 | - | 41 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.18 | - | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $48 | $45.56 | +5.36% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.11 | +80.02% | 9 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $30.99 | - | 20 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $27 | $14.93 | +80.84% | 12 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.69 | +77.51% | 32 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $29.35 | +138.50% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $2.36 | n/a | 20 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $4.37 | n/a | 31 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.2495 | n/a | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $6.52 | n/a | 15 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $10.14 | n/a | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $5.74 | n/a | 24 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $6 | $5.65 | n/a | 17 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $30.01 | n/a | 7 | Oct 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $216 → $197 | $15.78 | n/a | 3 | Nov 6, 2020 |
Absci
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $7.00
Upside: +71.43%
REGENXBIO
May 15, 2026
Maintained: Buy
Price Target: $17
Current: $6.93
Upside: +145.31%
Mirum Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $100 → $154
Current: $101.55
Upside: +51.65%
enGene Therapeutics
May 8, 2026
Downgraded: Hold
Price Target: $14 → $2
Current: $1.75
Upside: +14.29%
Intellia Therapeutics
Apr 27, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $14.55
Upside: +140.55%
Camp4 Therapeutics
Apr 2, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $4.13
Upside: +117.92%
Rocket Pharmaceuticals
Mar 27, 2026
Rated: Hold
Price Target: $7 → $11
Current: $2.80
Upside: +292.86%
Arrowhead Pharmaceuticals
Mar 26, 2026
Maintained: Hold
Price Target: n/a
Current: $76.55
Upside: -
Moderna
Feb 11, 2026
Maintained: Sell
Price Target: $12
Current: $55.40
Upside: -78.34%
Alnylam Pharmaceuticals
Dec 15, 2025
Maintained: Hold
Price Target: $370 → $351
Current: $281.90
Upside: +24.51%
Dec 15, 2025
Maintained: Buy
Price Target: $68 → $100
Current: $73.09
Upside: +36.82%
Dec 15, 2025
Maintained: Buy
Price Target: $370 → $86
Current: $66.64
Upside: +29.05%
Dec 15, 2025
Maintained: Buy
Price Target: $3 → $2
Current: $0.68
Upside: +194.12%
Oct 21, 2025
Maintained: Buy
Price Target: $20 → $18
Current: $4.75
Upside: +278.95%
Oct 15, 2025
Maintained: Buy
Price Target: $56 → $74
Current: $52.02
Upside: +42.25%
Oct 15, 2025
Maintained: Buy
Price Target: n/a
Current: $8.67
Upside: -
Oct 15, 2025
Maintained: Hold
Price Target: n/a
Current: $3.18
Upside: -
Sep 25, 2025
Maintained: Buy
Price Target: $51 → $48
Current: $45.56
Upside: +5.36%
Sep 23, 2025
Reiterated: Buy
Price Target: $20
Current: $11.11
Upside: +80.02%
Sep 3, 2025
Maintained: Buy
Price Target: n/a
Current: $30.99
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $32 → $27
Current: $14.93
Upside: +80.84%
Aug 13, 2025
Reiterated: Buy
Price Target: $3
Current: $1.69
Upside: +77.51%
Aug 12, 2025
Reiterated: Buy
Price Target: $70
Current: $29.35
Upside: +138.50%
Mar 6, 2025
Maintained: Hold
Price Target: $1
Current: $2.36
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $1
Current: $4.37
Upside: n/a
Jul 15, 2024
Maintained: Buy
Price Target: n/a
Current: $0.2495
Upside: n/a
Nov 13, 2023
Maintained: Hold
Price Target: $21
Current: $6.52
Upside: n/a
Jun 8, 2023
Maintained: Sell
Price Target: n/a
Current: $10.14
Upside: n/a
May 23, 2023
Reiterated: Hold
Price Target: $6 → $5
Current: $5.74
Upside: n/a
Nov 14, 2022
Reiterated: Hold
Price Target: $5 → $6
Current: $5.65
Upside: n/a
Oct 19, 2021
Maintained: Hold
Price Target: n/a
Current: $30.01
Upside: n/a
Nov 6, 2020
Maintained: Buy
Price Target: $216 → $197
Current: $15.78
Upside: n/a